DE69025230D1 - 2,5-Diaryl-tetrahydrofurane und deren Analoge als PAF-Antagonisten - Google Patents

2,5-Diaryl-tetrahydrofurane und deren Analoge als PAF-Antagonisten

Info

Publication number
DE69025230D1
DE69025230D1 DE69025230T DE69025230T DE69025230D1 DE 69025230 D1 DE69025230 D1 DE 69025230D1 DE 69025230 T DE69025230 T DE 69025230T DE 69025230 T DE69025230 T DE 69025230T DE 69025230 D1 DE69025230 D1 DE 69025230D1
Authority
DE
Germany
Prior art keywords
analogs
paf antagonists
diaryl tetrahydrofurans
tetrahydrofurans
diaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69025230T
Other languages
English (en)
Inventor
Tesfaye Biftu
Nirindar N Girotra
Mitree M Ponpipom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69025230D1 publication Critical patent/DE69025230D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Formation Of Insulating Films (AREA)
DE69025230T 1989-06-08 1990-06-08 2,5-Diaryl-tetrahydrofurane und deren Analoge als PAF-Antagonisten Expired - Lifetime DE69025230D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36292089A 1989-06-08 1989-06-08
US07/505,712 US4977146A (en) 1989-06-08 1990-04-11 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists

Publications (1)

Publication Number Publication Date
DE69025230D1 true DE69025230D1 (de) 1996-03-21

Family

ID=27001844

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69025230T Expired - Lifetime DE69025230D1 (de) 1989-06-08 1990-06-08 2,5-Diaryl-tetrahydrofurane und deren Analoge als PAF-Antagonisten

Country Status (14)

Country Link
US (1) US4977146A (de)
EP (1) EP0402151B1 (de)
JP (1) JPH07100701B2 (de)
KR (1) KR910000688A (de)
AT (1) ATE133947T1 (de)
AU (1) AU636615B2 (de)
CA (1) CA2018482A1 (de)
DE (1) DE69025230D1 (de)
FI (1) FI902846A0 (de)
IL (1) IL94585A0 (de)
NO (1) NO902513L (de)
NZ (1) NZ233903A (de)
PT (1) PT94302A (de)
ZA (1) ZA904391B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114961A (en) * 1989-06-08 1992-05-19 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5171864A (en) * 1991-08-30 1992-12-15 Allergan, Inc. Di-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega alkane-dioates and N,N-bis-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents
US5169963A (en) * 1991-08-30 1992-12-08 Allergan, Inc. Di-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega alkanedioates and N,N-bis-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
CA2140034A1 (en) 1992-07-13 1994-01-20 Xiong Cai 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
CA2194064C (en) * 1994-06-27 2009-03-17 Xiong Cai Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
EP0875247B1 (de) * 1997-04-18 2003-05-28 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Blutlipoproteinspiegel regulierendes Präparat
US6444664B1 (en) 1997-04-18 2002-09-03 Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
US6372922B1 (en) * 2001-03-27 2002-04-16 Council Of Scientific And Industrial Research Process for the production of (−) 3,4-divanillyl tetrahydrofuran
AR084486A1 (es) 2010-10-01 2013-05-22 Basf Se Compuestos de imina
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769350A (en) * 1968-12-09 1973-10-30 Hoffmann La Roche Method for making 2,3-dimethyl-1,4-bis(3,4 - hydrocarbonyloxyphenyl) - 1,4-butanedione
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
US4757084A (en) * 1984-02-29 1988-07-12 Merck & Co., Inc. 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists
IT8434016V0 (it) * 1984-03-12 1984-03-12 Zanussi A Spa Industrie Perfezionamenti ai dispositivi ammortizzatori ad attrito per lavabiancheria.
US4595693A (en) * 1984-06-04 1986-06-17 Merck & Co., Inc. Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
NZ215866A (en) * 1985-04-22 1989-11-28 Merck & Co Inc 2,5-di(aryl/heterocyclyl) tetrahydro-furans and pharmaceutical compositions
GB2197650A (en) * 1986-11-21 1988-05-25 Merck & Co Inc Process for preparing 2,5-diphenyl tetrahydrofurans and analogs thereof
NZ227287A (en) * 1987-12-21 1992-01-29 Merck & Co Inc 2,5-diaryl tetrahydrofurans and medicaments

Also Published As

Publication number Publication date
AU5692690A (en) 1990-12-13
AU636615B2 (en) 1993-05-06
IL94585A0 (en) 1991-04-15
US4977146A (en) 1990-12-11
NO902513L (no) 1990-12-10
EP0402151A1 (de) 1990-12-12
NO902513D0 (no) 1990-06-06
FI902846A0 (fi) 1990-06-07
ZA904391B (en) 1991-03-27
JPH03101670A (ja) 1991-04-26
PT94302A (pt) 1991-02-08
EP0402151B1 (de) 1996-02-07
ATE133947T1 (de) 1996-02-15
JPH07100701B2 (ja) 1995-11-01
KR910000688A (ko) 1991-01-30
NZ233903A (en) 1992-09-25
CA2018482A1 (en) 1990-12-08

Similar Documents

Publication Publication Date Title
DE69025230D1 (de) 2,5-Diaryl-tetrahydrofurane und deren Analoge als PAF-Antagonisten
RO85266B (ro) Compozitie erbicida
ES2053010T3 (es) Derivados del salicilaldehido y del acido salicilico asi como sus analogos azufrados, procedimiento para su obtencion y su empleo como herbicidas y biorreguladores.
FI873303A0 (fi) Karbapenemderivat, foerfarande foer tillverkning av dessa och sammansaettningar innehaollande dessa. dessa.
ATE240734T1 (de) Zubereitung von xanthinderivaten als feste dispersion
ATE243697T1 (de) Substitutierte heterozyclische derivate als crf antagonisten
DE69331721T2 (de) Neue carbamazepin hapten Analoge
ES2094772T3 (es) Derivados de imidazonaftiridinas.
DK0382660T3 (da) Dioxaphosphorinanforbindelser og dermed stabiliserede polyolefinmaterialer
DE69022279D1 (de) 1-Arylimidazol-Pestizide.
FI834730A0 (fi) 1-karboxialkanoylperhydro-indol-2-karboxylsyror och deras derivat
ES2046641T3 (es) Composicion antitumoral.
KR930703253A (ko) 고리형 화합물
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
DK0390138T3 (da) Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddel
GR81941B (de)
DE69829409D1 (de) Alkylaminoderivate
AU531543B2 (en) Anilido-urethanes
ES2159729T3 (es) Derivados de pirazolo(1,5-a)pirimidina.
DK0538517T3 (da) Nye organo-tinforbindelser med antitumoraktivitet og antitumormidler
ATE99306T1 (de) Antagonisten von leukotrien d4.

Legal Events

Date Code Title Description
8332 No legal effect for de